These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy. Lai JI; Wang WS; Lai YC; Lin PC; Chang SC Int J Clin Pharmacol Ther; 2010 Jul; 48(7):425-8. PubMed ID: 20557834 [TBL] [Abstract][Full Text] [Related]
4. Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX. Vargas A; Montironi C; Buxó E Arch Bronconeumol; 2015 Nov; 51(11):610. PubMed ID: 26163115 [No Abstract] [Full Text] [Related]
5. Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient. De Weerdt A; Dendooven A; Snoeckx A; Pen J; Lammens M; Jorens PG BMC Cancer; 2017 Aug; 17(1):586. PubMed ID: 28851379 [TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease associated with oxaliplatin: description of two cases. Pena Alvarez C; Suh Oh HJ; Sáenz de Miera Rodríguez A; García Arroyo FR; Covela Rúa M; Salgado Boquete L; López Clemente PM; Constenla Figueiras M Clin Transl Oncol; 2009 May; 11(5):332-3. PubMed ID: 19451069 [No Abstract] [Full Text] [Related]
7. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX). Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215 [No Abstract] [Full Text] [Related]
8. [Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin]. Park S; Jung JJ; Kim GB; Yoon HS; Ko SH; Ko JE; Lee YS Korean J Gastroenterol; 2010 May; 55(5):340-3. PubMed ID: 20697195 [TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication. Sánchez Cendra C; Juez Martel I; Gutierrez Abad D Arch Bronconeumol; 2017 Apr; 53(4):213-215. PubMed ID: 27756654 [No Abstract] [Full Text] [Related]
11. Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Garrido M; O'Brien A; González S; Clavero JM; Orellana E Chest; 2007 Dec; 132(6):1997-9. PubMed ID: 18079234 [TBL] [Abstract][Full Text] [Related]
12. [A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)]. Nakagawa M; Hamada A; Yoshihara Y; Ishizaka T; Fukushima M; Takahashi N; Sawada R; Mukai J Gan To Kagaku Ryoho; 2011 Feb; 38(2):317-20. PubMed ID: 21368504 [TBL] [Abstract][Full Text] [Related]
13. Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX). Muneoka K; Shirai Y; Sasaki M; Wakai T; Sakata J; Hatakeyama K Int J Clin Oncol; 2009 Oct; 14(5):457-9. PubMed ID: 19856057 [TBL] [Abstract][Full Text] [Related]
14. Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse event. Wenzel C; Urbauer E; Schwarz C; Funk G; Oehler L; Kornek GV; Scheithauer W Anticancer Drugs; 2006 Aug; 17(7):865-8. PubMed ID: 16926637 [TBL] [Abstract][Full Text] [Related]
15. Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer. Gagnadoux F; Roiron C; Carrie E; Monnier-Cholley L; Lebeau B Am J Clin Oncol; 2002 Aug; 25(4):388-90. PubMed ID: 12151971 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience. Kim CA; Spratlin JL; Armstrong DE; Ghosh S; Mulder KE Clin Colorectal Cancer; 2014 Sep; 13(3):199-206. PubMed ID: 25088184 [TBL] [Abstract][Full Text] [Related]
18. The spectrum of 5-fluorouracil cardiotoxicity. Dalzell JR; Samuel LM Anticancer Drugs; 2009 Jan; 20(1):79-80. PubMed ID: 19353811 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer. Fuse N; Doi T; Ohtsu A; Takeuchi S; Kojima T; Taku K; Tahara M; Muto M; Asaka M; Yoshida S Jpn J Clin Oncol; 2007 Jun; 37(6):434-9. PubMed ID: 17656481 [TBL] [Abstract][Full Text] [Related]
20. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer? Twelves C Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299 [No Abstract] [Full Text] [Related] [Next] [New Search]